Back to search
Central Line Bloodstream Infections
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Central Line Bloodstream Infections trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Central Line Bloodstream Infections trials you may qualify forThe purpose of this study is to evaluate the safety and pharmacokinetics (PK) of AZD7760 when given as an intravenous infusion to healthy participants (Phase I)…
This is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult partici…
In recent years, with the rapid advancement of medical technology and the rapid development of critical care medicine, the use of various central venous cathete…
The goal of this type of study is to construct the continuous quality promotion project "ICU-NO CRBSI(Catheter-Related Bloodstream Infection , CRBSI)" based on…
This study is a post-marketing approval requirement to assess the safety and time to Catheter-related Bloodstream Infections (CRBSI) of DefenCath in pediatric p…
Randomised, single-blind clinical trial comparing chlorhexidine gluconate-impregnated transparent dressings versus conventional transparent dressings in the pre…
The goal of this clinical trial is to compare a chlorhexidine antimicrobial barrier cap in patients requiring hemodialysis treatment to the standard hemodialysi…
This study evaluates the potential interest of a new multi-lumen infusion access device (Edelvaiss® Multiline NEO) in the prevention of catheter-related bactere…